Skip to Content

Peginterferon Beta-1a

In the US, Peginterferon Beta-1a (peginterferon beta-1a systemic) is a member of the drug class interferons and is used to treat Multiple Sclerosis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L03AB13

CAS registry number (Chemical Abstracts Service)

1211327-92-2

Chemical Formula

C913-H1417-N246-O256-P-S7[C2-H4-O]n

Molecular Weight

44000

Therapeutic Categories

Immunomodulator

Treatment of multiple sclerosis, MS

Chemical Name

N².¹ -{(2RS)-2-methyl-3-[ω-methoxypoly(oxyethylene)]propyl}human interferon beta (fibroblast interferon, IFN-beta) glycosylated expressed in mammalian cells (WHO)

Foreign Names

  • Peginterferonum beta-1a (Latin)
  • Peginterferon beta-1a (German)
  • Peginterféron bêta-1a (French)
  • Peginterferón beta-1a (Spanish)

Generic Names

  • Peginterferon Beta-1a (OS: USAN)
  • UNII-I8309403R0 (IS)

Brand Names

  • Avonex
    Biogen Idec, Macedonia
  • Plegridy
    Biogen, Germany; Biogen, Denmark; Biogen, Ireland; Biogen idec, Finland; Biogen Switzerland, Switzerland; BiogenIdec, Sweden
  • Rebif NF
    Merck, Mexico

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide